Cannabis start-up investors in the dark on failed $180m deal
A $180 million deal with Rhizo Sciences is up in smoke but PlegeMe investors haven't been told.
Dane Ambler
Tue, 06 Nov 2018
Medicinal cannabis start-up Hikurangi Enterprises denies it counted its seedlings before they flowered when it lured unwitting investors in on the basis of a deal that hasn't gone ahead.
The Ruatoria-based company, which was the first in New Zealand to secure a licence to cultivate medicinal
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
NZ Aviation News
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Aviation News - Monthly
NZ$14.95 / monthly
Already have an account? Login
Dane Ambler
Tue, 06 Nov 2018
Contact the Writer: dane@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Cannabis start-up investors in the dark on failed $180m deal
Business,
77102